Protara Therapeutics Inc (TARA)
2.89
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
2.89
0.00 (0.00%)
After-Hours: 18:30
Protara Therapeutics Cash and Short Term Investments (Quarterly): 65.58M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 65.58M |
| September 30, 2023 | 74.03M |
| June 30, 2023 | 80.36M |
| March 31, 2023 | 86.61M |
| December 31, 2022 | 84.37M |
| September 30, 2022 | 96.32M |
| June 30, 2022 | 98.46M |
| March 31, 2022 | 87.59M |
| December 31, 2021 | 91.23M |
| Date | Value |
|---|---|
| September 30, 2021 | 93.76M |
| June 30, 2021 | 84.67M |
| March 31, 2021 | 84.34M |
| December 31, 2020 | 168.60M |
| September 30, 2020 | 165.90M |
| June 30, 2020 | 29.97M |
| March 31, 2020 | 36.07M |
| December 31, 2019 | 0.564M |
| September 30, 2019 | 41.86M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.564M
Minimum
Dec 2019
168.60M
Maximum
Dec 2020
81.68M
Average
84.52M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| AngioDynamics Inc | 78.45M |
| Regulus Therapeutics Inc | 23.77M |
| Bio-Path Holdings Inc | 1.052M |
| Outset Medical Inc | 203.32M |
| AN2 Therapeutics Inc | 107.30M |